Did anyone’s pick up that the aim this FY is to achieve $9M ARR....

Did anyone’s pick up that the aim this FY is to achieve $9M ARR.

Sitting at 3.6 this represents 250% increase. This would be $1.3M per quarter. If this is the case watch out for a big shift in SP at then end of July when co formed in the 1/4 update.

I was wondering why the SP continued to hold at 30% premium above the credit rate se price and there was no sell down. People are Cleary waiting for this to take off! Xero is the recent memory stock that went from strength to strength every Capital raise.

I’m very much holding waiting for two things:

1) quartet update showing over $1M in sales (big stretch if it does)
2) October for the go live of VHT in the NHS trial in UK - this has the potential to be rolled out across the entire NHS. This could be HUGE!